Max Robotics — Global Service Robot Directory + US Certification

About

Euihwan Kim is a urologic oncologist whose research focuses on advancing surgical outcomes in bladder cancer treatment, particularly through robotic-assisted techniques. As a key contributor to the International Robotic Cystectomy Consortium, Kim has helped establish long-term evidence for robot-assisted radical cystectomy, demonstrating its oncologic efficacy over a ten-year follow-up period. His work addresses critical questions in urologic oncology, including surgical morbidity, recurrence patterns, and survival outcomes in patients undergoing minimally invasive bladder cancer surgery. While his most cited paper, a reply to a letter regarding ten-year oncologic outcomes from the consortium, has garnered 2 citations, it reflects his role in refining and defending the evidence base for robotic cystectomy. Kim's contributions are part of a broader effort to validate robotic surgery as a standard of care for muscle-invasive bladder cancer, influencing surgical protocols and patient selection criteria. His research continues to shape the field by providing long-term data that supports the safety and effectiveness of robotic approaches in complex urologic oncology cases.